These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11315085)

  • 41. Optimal spending functions for asymmetric group sequential designs.
    Anderson KM
    Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adaptive designs with correlated test statistics.
    Götte H; Hommel G; Faldum A
    Stat Med; 2009 May; 28(10):1429-44. PubMed ID: 19226563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interim analysis and sample size reassessment.
    Posch M; Bauer P
    Biometrics; 2000 Dec; 56(4):1170-6. PubMed ID: 11129475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Issues in designing flexible trials.
    Posch M; Bauer P; Brannath W
    Stat Med; 2003 Mar; 22(6):953-69. PubMed ID: 12627412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequential conditional probability ratio tests for normalized test statistic on information time.
    Xiong X; Tan M; Boyett J
    Biometrics; 2003 Sep; 59(3):624-31. PubMed ID: 14601763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient group sequential designs when there are several effect sizes under consideration.
    Jennison C; Turnbull BW
    Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-stage designs for cross-over bioequivalence trials.
    Kieser M; Rauch G
    Stat Med; 2015 Jul; 34(16):2403-16. PubMed ID: 25809815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statistical analysis of noninferiority trials with a rate ratio in small-sample matched-pair designs.
    Chan IS; Tang NS; Tang ML; Chan PS
    Biometrics; 2003 Dec; 59(4):1170-7. PubMed ID: 14969498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal clinical trials with adaptive choice of follow-up time.
    Jeffries N; Geller NL
    Biometrics; 2015 Jun; 71(2):469-77. PubMed ID: 25818116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Properties of a nonparametric test for early comparison of treatments in clinical trials in the presence of surrogate endpoints.
    Venkatraman ES; Begg CB
    Biometrics; 1999 Dec; 55(4):1171-6. PubMed ID: 11315064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of adaptive designs: efficiency evaluation.
    Menon S; Chang M
    J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjusting for regression effect in uncontrolled studies.
    Naranjo JD; McKean JW
    Biometrics; 2001 Mar; 57(1):178-81. PubMed ID: 11252595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Confidence interval construction for proportion difference in small-sample paired studies.
    Tang ML; Tang NS; Chan IS
    Stat Med; 2005 Dec; 24(23):3565-79. PubMed ID: 16261646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calculation of sample size in survival trials: the impact of informative noncompliance.
    Jiang Q; Snapinn S; Iglewicz B
    Biometrics; 2004 Sep; 60(3):800-6. PubMed ID: 15339304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal adaptive group sequential design with flexible timing of sample size determination.
    Cui L; Zhang L; Yang B
    Contemp Clin Trials; 2017 Dec; 63():8-12. PubMed ID: 28455234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On sample size determination in multi-armed confirmatory adaptive designs.
    Wassmer G
    J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate.
    Lehmacher W; Wassmer G; Reitmeir P
    Biometrics; 1991 Jun; 47(2):511-21. PubMed ID: 1912258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.